Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/ hyperactivity disorder. Evidence from 2 birth cohorts

Archives of General Psychiatry

Volumn 63, Issue 4, 2006, Pages 462-469

  Mill, Jonathan ^a   Caspi, Avshalom ^a,b   Williams, Benjamin S ^a   Craig, Ian ^a   Taylor, Alan ^a   Polo Tomas, Monica ^a   Berridge, Craig W ^b   Poulton, Richie ^c   Moffitt, Terrie E ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASES IN TWINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENETIC HETEROGENEITY; GREAT BRITAIN; HUMANS; INTELLIGENCE; LONGITUDINAL STUDIES; MALE; NEW ZEALAND; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, DOPAMINE D4; TANDEM REPEAT SEQUENCES;

EID: 33645502924     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.63.4.462     Document Type: Article

References (64)

1. Hyman SE. Foreword. In: Phillips KA, First MB, Pincus HA, eds. Advancing DSM: Dilemmas in Psychiatric Diagnosis. Washington, DC: American Psychiatric Association; 2003.
2. Bearden CE, Reus VI, Freimer NB. Why genetic investigation of psychiatric disorders is so difficult. Curr Opin Genet Dev. 2004;14:280-286.
3. Castellanos FX, Tannock R. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002;3:617-628.
4. Nigg JT, Willcutt EG, Doyle AE, Sonuga-Barke EJS. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57:1224-1230.
5. Barkley RA. Behavioural inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121:65-94.
6. Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry. 1997;36:1065-1079.
7. McGough JJ. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatry. 2005;57:1367-1373.
8. Barkley RA, Fischer M, Smallish L, Fletcher M. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111:279-289.
9. Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005;90(suppl):i2-i7.
10. Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;9:711-726.
11. Nigg JT, Huang-Pollock CL. An early-onset model of the role of executive functions and intelligence in conduct-disorder/delinquency. In: Lahey B, Moffitt TE, Caspi A, eds. Causes of Conduct-Disorder and Juvenile Delinquency. New York, NY: Guilford Press; 2003.
12. Gray JR, Thompson PM. Neurobiology of intelligence: science and ethics. Nat Rev Neurosci. 2004;5:471-482.
13. Frazier TW, Demaree HW, Youngstrom EA. Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology. 2004;18:543-555.
14. Mariani MA, Barkley RA. Neuropsychological and academic functioning in preschool boys with attention deficit hyperactivity disorder. Dev Neuropsychol. 1997;13:111-129.
15. Moffitt TE. Juvenile delinquency and attention-deficit disorder: developmental trajectories from age three to fifteen. Child Dev. 1990;61:893-910.
16. Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, Kuiper M. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995;34:1025-1032.
17. Biederman J, Monuteaux MC, Doyle AE, Seidman LJ, Wilens TE, Ferrero F, Morgan CL, Faraone SV. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol. 2004;72:757-766.
18. Ingram S, Hechtman L, Morgenstern G. Outcome issues in ADHD: adolescent and adult long-terms outcome. Ment Retard Dev Disabil Res Rev. 1999;5:243-250.
19. Bobb AJ, Castellanos FX, Addington AM, Rapoport J. Molecular genetic studies of ADHD: 1991-2004. Am J Med Genet B Neuropsychiatr Genet. 2005;132:109-125.
20. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1313-1323.
21. Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross G, Bentley L, Hollis CP. Association of the dopamine transporter (DAT1) 10/1/0-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry. 2005;10:686-698.
22. Langley K, Marshall L, van den Bree M, Thomas H, Owen M, O'Donovan M, Thapar A. Association of the dopamine 4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry. 2004;161:133-138.
23. Swanson J, Oosterlaan J, Murias M, Schuck S, Flodman P, Spence MA, Wasdell M, Ding Y, Chi HC, Smith M, Mann M, Carlson C, Kennedy JL, Sergeant JA, Leung P, Zhang YP, Sadeh A, Chen C, Whalen CK, Babb KA, Moyzis R, Posner MI. Attention deficit/hyperactivity disorder in children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci U S A. 2000;97:4754-4759.
24. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 1995;65:1157-1165.
25. Madras BK, Miller GM, Fischman AJ. The dopamine transporter and attentiondeficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1397-1409.
26. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol. 2002;67:53-83.
27. Sagvolden T, Johanson EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD). Behav Brain Sci. 2005;28:397-468.
28. Mehta MA, Goodyer IM, Sahakian BJ. Methylphenidate improves working memory and set-shifting in ADHD: relationships to baseline memory capacity. J Child Psychol Psychiatry. 2004;45:293-305.
29. Cohen J, Cohen J. The clinician's illusion. Arch Gen Psychiatry. 1984;41:1178-1182.
30. Moffitt TE; E-Risk Study Team. Teen-aged mothers in contemporary Britain. J Child Psychol Psychiatry. 2002;43:201-235.
31. Trouton A, Spinath F, Plomin R. Twins' Early Development Study. Twin Res. 2002;5:444-448.
32. Bennett N, Jarvis L, Rowlands O, Singleton N, Haselden L. Living in Britain: Results From the General Household Survey. London, England: Her Majesty's Stationery Office; 1996.
33. StataCorp. STATA: Statistical Software. Release 8.2. College Station, Tex: StataCorp; 2005.
34. Moffitt TE, Caspi A, Rutter M, Silva PA. Sex Differences in Antisocial Behaviour: Conduct Disorder, Delinquency, and Violence in the Dunedin Longitudinal Study. Cambridge, England: Cambridge University Press; 2001.
35. Kuntsi J, Eley TC, Taylor A, Hughes C, Asherson P, Caspi A, Moffitt TE. Co-occurrence of ADHD and low IQ has genetic origins. Am J Med Genet B Neuropsychiatr Genet. 2004;124:41-47.
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
37. Costello A, Edelbrock C, Kalas R, Kessler M, Klaric S. National Institute of Mental Health Diagnostic Interview Schedule for Children. Rockville, Md: National Institute of Mental Health; 1982.
38. Anderson JC, Williams SM, McGee RO, Silva PA. DSM-III disorders in preadolescent children: prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987;44:69-76.
39. Frost LA, Moffitt TE, McGee R. Neuropsychological function and psychopathology in an unselected cohort of young adolescents. J Abnorm Psychol. 1989;98:307-313.
40. McGee R, Feehan M, Williams S, Partridge F, Silva PA, Kelly J. DSM-III disorders in a large sample of adolescents. J Am Acad Child Adolesc Psychiatry. 1990;29:611-619.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
42. Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-Revised. London, England: Psychological Corp; 1990.
43. Sattler J. Assessment of Children: WISC-III and WPPSI-R Supplement. San Diego, Calif: J Sattler; 1992.
44. Wechsler D. Manual for the Wechsler Intelligence Scale for Children-Revised. New York, NY: Psychological Corp; 1974.
45. Moffitt TE, Caspi A, Harkness AR, Silva PA. The natural history of change in intellectual performance: who changes? how much? is it meaningful? J Child Psychol Psychiatry. 1993;34:455-506.
46. Moffitt TE, Caspi A, Harrington H, Milne B. Males on the life-course-persistent and adolescence-limited antisocial pathways: follow-up at age 26 years. Dev Psychopathol. 2002;14:179-206.
47. Mill J, Caspi A, McClay J, Sugden K, Purcell S, Asherson P, Craig I, McGuffin P, Braithwaite A, Poulton R, Moffitt TE. The dopamine D4 receptor and the hyperactivity phenotype: a developmental-epidemiological study. Mol Psychiatry. 2002;7:383-391.
48. Kang AM, Palmatier MA, Kidd KK. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry. 1999;46:151-160.
49. Holmes J, Payton A, Barett J, Harrington R, McGuffin P, Owen M, Ollier W, Worthington J, Gill M, Kirley A, Hawi Z, Fitzgerald M, Asherson P, Curran S, Mill J, Gould A, Taylor E, Kent L, Craddock N, Thapar A. Association of DRD4 in children with ADHD and comorbid conduct problems. Am J Med Genet. 2002;114:150-153.
50. Rowe DC, Stever C, Chase D, Sherman S, Abramowitz A, Waldman ID. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatry. 2001;6:429-443.
51. Kim-Cohen J, Arseneault L, Caspi A, Polo Tomas M, Taylor A, Moffitt TE. Validity of DSM-IV conduct disorder in 41/2-5-year-old children: a longitudinal epidemiological study. Am J Psychiatry. 2005;162:1108-1117.
52. Barlow DH. Anxiety and Its Disorders. 2nd ed. New York, NY: Guilford Press; 2002.
53. Fergusson DM, Horwood LJ, Ridder EM. Show me the child at seven, II: childhood intelligence and later outcomes in adolescence and young adulthood. J Child Psychol Psychiatry. 2005;46:850-858.
54. Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne B, Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry. 2003;60:709-717.
55. Gottfredson LS. Why g matters: the complexity of everyday life. Intelligence. 1997;24:79-132.
56. Insel TR, Collins FS. Psychiatry in the genomics era. Am J Psychiatry. 2003;160:616-620.
57. Merikangas KR, Risch N. Will the genomics revolution revolutionize psychiatry? Am J Psychiatry. 2003;160:625-635.
58. Raskin LA, Shaywitz SE, Shaywitz BA, Anderson GM, Cohen DJ. Neurochemical correlates of attention deficit disorder. Pediatr Clin North Am. 1984;31:387-396.
59. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ, van 't Slot R, Minderaa RB, Gunning WB, Pearson PL, Sinke RJ. A wholegenome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet. 2003;72:1251-1260.
60. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, Newbury DF, Crawford LR, Palmer CG, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco AP, Smalley SL. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet. 2002;70:1183-1196.
61. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995;269:230-234.
62. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry. 2005;10:6-13.
63. Doyle AE, Faraone SV, Seidman LJ, Willcutt EG, Nigg JT, Waldman ID, Pennington BF, Peart J, Biederman J. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry. 2005;46:774-803.
64. Krishnan KR. Psychiatric disease in the genomic era: rational approach. Mol Psychiatry. 2005;10:978-984.